These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8350757)

  • 21. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
    Perkins S; Foung SK
    Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficient electric field-induced generation of hybridomas from human B lymphocytes without prior activation in vitro.
    Kwekkeboom J; de Groot C; Tager JM
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):48-53. PubMed ID: 1576322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The adaptive response of B cells in culture to the action of cytotoxic agents. I. The stimulation of immunoglobulin synthesis and secretion by myeloma cells, hybridomas and human lymphocytes under the influence of adriamycin and ethidium bromide].
    Davtian TK; Meliksetian MB; Ignatova TN; Aleksanian IuT
    Tsitologiia; 1993; 35(4):54-60. PubMed ID: 8328024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved fusion partners transfected with DNA fragment encoding IL-11 on generation of human B lymphocyte hybridomas.
    Zhu Y; Jin B; Jiang S; Sun K; Sun C; Liu X
    Hum Antibodies; 1999; 9(1):1-7. PubMed ID: 10331181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The generation of Ig-secreting UC 729-6 derived human hybridomas by electrofusion.
    Pratt M; Mikhalev A; Glassy MC
    Hybridoma; 1987 Oct; 6(5):469-77. PubMed ID: 3500113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current developments in hybridoma technology].
    Osterhaus AD; UytdeHaag AG
    Tijdschr Diergeneeskd; 1985 Oct; 110(20):835-9. PubMed ID: 3878011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of proliferation of a murine myeloma cell line and mitogen-stimulated B lymphocytes by the antibiotic amphotericin B (Fungizone).
    Walls EV; Kay JE
    Immunology; 1982 Sep; 47(1):115-21. PubMed ID: 6981585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The EBV-hybridoma technique.
    Roder JC; Cole SP; Kozbor D
    Methods Enzymol; 1986; 121():140-67. PubMed ID: 3014265
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
    Glaser RW; Jahn S; Grunow R
    Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis.
    Ray S; Diamond B
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5548-51. PubMed ID: 8202525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
    Togawa A; Inoue N; Mannoji M; Namba M
    Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
    Gore MM; Singhania SS; Basu A; Banerjee K
    Hum Antibodies; 1997; 8(1):26-32. PubMed ID: 9265502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency.
    Denis KA; Wall R; Saxon A
    J Immunol; 1983 Nov; 131(5):2273-8. PubMed ID: 6313803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efforts to produce human cytotoxic T-cell hybridomas by electrofusion and PEG fusion.
    Gravekamp C; Santoli D; Vreugdenhil R; Collard JG; Bolhuis RL
    Hybridoma; 1987 Apr; 6(2):121-33. PubMed ID: 3494659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
    Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
    Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immortalization of magnetically separated human lymphocytes by electrofusion.
    Glaser RW; Volk HD; Liebenthal C; Jahn S; Grunow R
    Hum Antibodies Hybridomas; 1990; 1(2):111-4. PubMed ID: 1715775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow.
    Başalp A; Yücel F
    Hybrid Hybridomics; 2003 Oct; 22(5):329-31. PubMed ID: 14678651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-step technique for selecting and cloning hybridomas for monoclonal antibody production.
    Davis JM
    Methods Enzymol; 1986; 121():307-22. PubMed ID: 3487692
    [No Abstract]   [Full Text] [Related]  

  • 40. Cell hybrids: an important new source of antibody production.
    Blann AD
    Med Lab Sci; 1979; 36(4):329-38. PubMed ID: 392214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.